Semisynthesis and biological evaluation of (+)-sclerotiorin derivatives as antitumor agents for the treatment of hepatocellular carcinoma.
Semisynthesis and biological evaluation of (+)-sclerotiorin derivatives as antitumor agents for the treatment of hepatocellular carcinoma.
复制标题
DOI:
10.1016/j.ejmech.2022.114166
复制
发表时间:
2022-02
影响因子:
6.7
通讯作者:
Yang Hai;Jiaqing Geng;Peng Li;W. Ma;Cui-Fang Wang;Mei-Yan Wei;Xue-Mei Hou;Guangying Chen;
中科院分区:
文献类型:
--
作者:
Yang Hai;Jiaqing Geng;Peng Li;W. Ma;Cui-Fang Wang;Mei-Yan Wei;Xue-Mei Hou;Guangying Chen;
Hepatocellular carcinoma is one of the most common primary hepatic malignancy. Herein, a series of semisynthesized derivatives (2–30) of the natural product (+)-sclerotiorin (1) was prepared and evaluated the cytotoxic activities against six cancer cell lines. Among them,3and5were the most effective compounds against human hepatocellular carcinoma Bel-7402 cell line with IC50values of 1.45 and 1.15μM, respectively. Molecular mechanism study showed that5disrupted the mitochondrial membrane potential and induced apoptosis in a caspase-dependent manner. In addition,5affected AKT and ERK signaling pathways and induced AKT and ERK proteins degradation through ubiquitin-proteasome system. Furthermore,5displayed significantin vivoanticancer effects in the xenograft models with decreasing the tumor mass by 52.5%. The safety evaluation was confirmed by acute toxicity subchronic toxicity tests, paraffin sections of mice organ and blood routine examination. Taken together,5can be developed as a potential therapeutic agent for hepatocellular carcinoma.